Surajeet Das Gupta &Amp; Sohini Das

Stories by Surajeet Das Gupta &Amp; Sohini Das

5 years of Reliance Jio: Disruption to Data Revolution

5 years of Reliance Jio: Disruption to Data Revolution

Rediff.com   21 Sep 2021

'There is no doubt at all that Jio's disruption of the mobile broadband market was a turning point for India's digital economy.'

Mystery fever in wake of falling Covid cases raises alarm

Mystery fever in wake of falling Covid cases raises alarm

Rediff.com   20 Sep 2021

The sudden spike in cases of fever in India has claimed over 100 lives in five states, including UP, MP, Bihar, Haryana, and West Bengal. In UP, Firozabad and Mathura alone have reported 72 cases.

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Explained: What USFDA full approval to Pfizer-BioNTech vaccine means

Rediff.com   17 Sep 2021

Pfizer can show the FDA approval to the Indian regulator and present a case that based on whatever data submitted, the US regulator has granted a full marketing nod, says Sohini Das.

Ban on Chinese mobile apps is bonanza for India's own

Ban on Chinese mobile apps is bonanza for India's own

Rediff.com   17 Sep 2021

Eighteen months after the government started banning Chinese mobile apps, two distinct changes have occurred in the country's mobile app sweepstakes. The move has given a thrust to domestic app publishers, especially in certain segments and it has dramatically reduced the market share of Chinese apps. What started as an interim government ban on 59 Chinese apps, including the highly popular TikTok and WeChat in March 2020 ended as a permanent ban on many of them in January this year. According to a China Internet Report 2021 (by South China Morning Post), the market share of Chinese apps in India has dropped substantially from 44 per cent in 2018 to only 29 per cent in 2020. In 2017 it was 41 per cent.

Qualcomm's chips to power Ola's electric scooters

Qualcomm's chips to power Ola's electric scooters

Rediff.com   15 Sep 2021

From powering mobile devices, US chip designer Qualcomm has tied up with Ola Electric to power its electric scooters. Qualcomm is providing the key 4G connected octa core android platform which provides connectivity, computing capabilities and enables rich immersive displays with power saving software.

Covid Vaccine: Syringe manufacturers are ramping up

Covid Vaccine: Syringe manufacturers are ramping up

Rediff.com   15 Sep 2021

The Centre is looking to procure around 1 billion syringes between September and December to support the COVID-19 vaccination drive.

Gennova's mRNA vaccine to come in powder form, stay stable at 2-8C

Gennova's mRNA vaccine to come in powder form, stay stable at 2-8C

Rediff.com   14 Sep 2021

Gennova has also got permission for phase-2 and 3 clinical trials for its lyophilised mRNA vaccine for injection from the subject expert committee advising the Central Drugs Standards Control Organisation, reports Sohini Das.

Govt developing multi-variant Covid-19 vaccine

Govt developing multi-variant Covid-19 vaccine

Rediff.com   14 Sep 2021

Government institutions and pharma industry are examining if a 'cocktail' approach to making a multi-variant Covid-19 vaccine works against multiple strains of the ever-mutating virus, reports Sohini Das.

Tesla plans fully-owned retail outlets in India

Tesla plans fully-owned retail outlets in India

Rediff.com   14 Sep 2021

Palo Alto-based electric carmaker Tesla has initiated talks with the government on the modalities of setting up fully-owned retail outlets. The company needs to comply with the foreign direct investment (FDI) guidelines related to single-brand retail, including local sourcing norms, to sell directly in India. At least two other foreign majors - Apple and Ikea - were engaged in talks with the government long before the sourcing norms were eased under the single-brand retail route.

Airtel takes a leaf out of Jio as telecom battle intensifies

Airtel takes a leaf out of Jio as telecom battle intensifies

Rediff.com   13 Sep 2021

When, recently, Bharti Airtel announced a Rs 21,000 crore rights issue, analysts pointed out that its structure was similar to that of Reliance's issue in June 2020. One similarity is that shareholders in both companies have to pay only 25 per cent of the money on application. The rest is to be paid in two tranches. In Bharti Airtel's case, it is within 36 months; in Reliance Jio's, it is within 17 months.

'Made in India' iPhones make Apple's 70% India sales

'Made in India' iPhones make Apple's 70% India sales

Rediff.com   6 Sep 2021

In a major push towards 'Make in India', Apple Inc is manufacturing 70 per cent of the mobile phones, in value terms, that it sells in the domestic market, in India, according to sources aware of the development. This is a sharp rise from the figure of 30 per cent just two years ago and marks a major shift in Apple's strategy following the government's Production Linked Incentive (PLI) scheme that kicked off in FY'21. One of Apple's three vendors here, Foxconn, is currently manufacturing the best-selling model, the Apple 11, along with the Apple 10 and the Apple 12. Another contract manufacturer, Wistron, makes the Apple SE 2020. (The third, Pegatron, has yet to start production). The only models that are imported (they have limited volumes but high value) are the Apple 12 Pro and Pro Max.

China's tech crackdown may be good news for Indian start-ups

China's tech crackdown may be good news for Indian start-ups

Rediff.com   2 Sep 2021

The Chinese government is imposing severe restrictions on their tech companies - whether it is on data security, marketing practices or floating an IPO. Should this be music to the ears of Indian start-ups and home-grown private equity (PE) funds? Ask Indian start-ups and the answer is a resounding "yes".

Focus on hospitals as India braces for Covid third wave

Focus on hospitals as India braces for Covid third wave

Rediff.com   1 Sep 2021

The health system is trying to ensure that it isn't caught by surprise -- the way it was last time. So, hectic preparations are on.

Pharma majors shift focus to inhalants, nasal spray for Covid

Pharma majors shift focus to inhalants, nasal spray for Covid

Rediff.com   30 Aug 2021

While Lupin is working on a Remdesivir powder for inhalation, Glenmark has tied up with a Canadian Biotech firm for nitric oxide nasal spray that reduces Sars-CoV-2 viral load and thus transmission.

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Gennova's mRNA Covid vaccine gets nod for Phase 2-3 trials

Rediff.com   25 Aug 2021

If things go according to plan, the vaccine would be available in the market by the end of this year.

What if Vodafone Idea shuts shop?

What if Vodafone Idea shuts shop?

Rediff.com   21 Aug 2021

Reliance Jio and Bharti Airtel have enough capacity to absorb over 113.9 million Vodafone Idea subscribers who are on 4G if Vodafone Idea has to shut operations.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com   18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Govt stands to lose whether it saves debt-laden Vodafone Idea or not

Govt stands to lose whether it saves debt-laden Vodafone Idea or not

Rediff.com   12 Aug 2021

The government will have to make substantial payments, as well as forego revenues in FY'23, if it wants to work on the survival of Vodafone Idea because it will have to extend the same incentives to the entire telecom sector. According to estimates, the industry has to spend around Rs 21,000-Rs 25,000 crore for spectrum which it bought on a deferred payment basis. Vodafone Idea has asked for a moratorium for another year (FY23). If granted, the government will have foregone the instalment payout for a third year in a row as it has already provided a moratorium for two years, giving telcos Rs 42,000 crore worth of relief.

Ed-tech giant Byju's eyes $1 billion revenue in US by 2024

Ed-tech giant Byju's eyes $1 billion revenue in US by 2024

Rediff.com   11 Aug 2021

Byju's has quietly moved into other global markets such as the UK, Australia and New Zealand. It recently launched operations in Latin America.

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Despite nod foreign Covid vaccines likely to be delayed over indemnity clause

Rediff.com   11 Aug 2021

India is not keen to 'bow down' to demands related to indemnity against legal liabilities in case any vaccine recipient develops severe adverse reactions post inoculation.